Some Links (opens in new tab)

TweetCharley Hooper and David Henderson, writing in the Wall Street Journal, make a powerful case for the U.S. Food and Drug Administration to leave considerations of medications’ efficacy to doctors and their patients. Two slices: With distressing frequency, the Food and Drug Administration rejects safe drugs it says haven’t demonstrated enough efficacy. These pages documented […] The post appeared first on .